All Posts By

Alex Morgan (Guest Author)

Alex Morgan is a prominent figure in corporate wellness, specializing in the integration of personalized wellness plans into corporate programs. With a Master's degree in Public Health and over fifteen years of experience in employee well-being, Alex has worked with numerous Fortune 500 companies to enhance their wellness initiatives. His expertise in data-driven wellness strategies and his commitment to fostering a healthy work environment make him a sought-after consultant and speaker. Alex's innovative approaches and dedication to improving employee health and productivity have established him as a leader in the field of corporate wellness.

Jul 22

Love0

Customized Wellness Plans for Corporate Wellness Programs

By Alex Morgan (Guest Author) General Wellness

Boosting Employee Health and Productivity In today's competitive business environment, employee well-being is paramount. Customized wellness plans have emerged as a powerful tool to enhance employee health and productivity. This article delves into…

Medical Weight Loss

GPCR-Targeted Obesity Therapies: The Next Frontier Beyond GLP-1 Drugs

Takeaways Emerging GPCR-targeted therapies could offer oral, appetite-modifying weight-loss options with fewer GI side effects. GSBR-1290 shows real human efficacy (~5–7% weight loss) and convenience, while BRP highlights non-incretin, central-acting alternatives in preclinical…

Daxxify’s Role in Hormone-Sensitive Aesthetic Care

Testosterone Replacement Therapy

Daxxify’s Emerging Role in Hormone-Sensitive Aesthetic Medicine

Takeaways Daxxify offers significantly longer-lasting results (6–9 months) compared to traditional neuromodulators, making it especially appealing for patients with hormonal fluctuations. No peer-reviewed research yet exists linking Daxxify’s use to stabilizing estrogen-influenced dermal changes,…

Designer Estrogens 2.0: Tissue-Selective HRT Without Cancer Risk

Testosterone Replacement Therapy

Designer Estrogens 2.0: A New Era in Tissue-Selective Hormone Therapy

Takeaways Designer Estrogens 2.0 offer targeted bone and cognitive benefits while minimizing breast and uterine cancer risks. The 2025 UCSF Phase II trial shows improved bone density and memory with no evidence of…

CHECK OUT OUR BLOG HERE